| | LUND, Sweden, Feb. 25, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company’s management team will participate in the following upcoming investor conferences: - Cowen and Company’s 40th Annual Health Care Conference in Boston on Monday, March 2, 2020, with a presentation at 4:10 PM EST/ 22:10 CET on the same day.
- The Carnegie Nordic Healthcare Seminar in Stockholm on Wednesday, March 4, 2020, with a presentation at 8:00 AM CET
A live webcast of the Cowen presentation will be available on the Events & Webcast page of the Company’s website, www.hansabiopharma.com . A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation. Calendar 2020 | Feb 27-28, 2020 | Road Show Cowen, Chicago/Dallas | | Mar 2, 2020 | Cowen Annual Health Care Conference, Boston | | Mar 4, 2020 | Road Show Argot, New York City | | Mar 4, 2020 | Carnegie Nordic Healthcare Seminar, Stockholm | | Mar 26, 2020 | Kempen Expert Call with Prof. Mårten Segelmark on Anti-GBM | | Apr 2, 2020 | Annual Report 2019 | | Apr 21-22, 2020 | Kempen Life Sciences Conference, Amsterdam | | Apr 28, 2020 | Interim Report Jan-Mar 2020 | | May 5, 2020 | Annual General Meeting | | May 18, 2020 | UBS Global Healthcare Conference, NYC | | May 19, 2020 | RBC Global Healthcare Conference, NYC | | May 26, 2020 | ABG Life Science Summit, Stockholm | | May 27, 2020 | Ökonomisk Ugebrev Life Science Conference, Copenhagen | | Jul 16, 2020 | Interimn Report Jan-Jul 2020 | | Sep 16-17, 2020 | Bank of America Merill Lynch Global Healthcare Conf., London | | Oct 22, 2020 | Interimn Report Jan-Sep 2020 | CONTACT: For further information, please contact:
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma
Mobile: +46 (0) 709-298 269
E-mail: klaus.sindahl@hansabiopharma.com Rolf Gulliksen
Head of Corporate Communications
Hansa Biopharma
Mobile: +46 (0) 733-328 634
E-mail: rolf.gulliksen@hansabiopharma.com This information was brought to you by Cision http://news.cision.com https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-to-participate-in-two-upcoming-investor-conferences,c3043193 The following files are available for download:  View original content:http://www.prnewswire.com/news-releases/hansa-biopharma-to-participate-in-two-upcoming-investor-conferences-301010445.html
SOURCE Hansa Biopharma AB | |
| |
Company Codes: Berlin:24H, Bloomberg:HNSA@SS, ISIN:SE0002148817, LSE:0RC7, Mexico:HNSA, OTC-PINK:HNSBF, RICS:HNSA.ST, Frankfurt:24H, Stockholm:HNSA, Stuttgart:24H | |
